
Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
Description
Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
Value sales of cough, cold, and allergy (hay fever) remedies continue to rise in 2022, driven by demand for combination products, cough remedies, nasal sprays and pharyngeal preparations, a scenario that is benefiting brands such as Panpyrin Q, Pancold S, Haben, Care Gargle, and other cold-related treatments by major pharmaceutical companies. Sales of these products in late 2021 and early 2022 increased rapidly due to a surge in number of confirmed Omicron cases in South Korea, encouraging consu...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Value sales of cough, cold, and allergy (hay fever) remedies continue to rise in 2022, driven by demand for combination products, cough remedies, nasal sprays and pharyngeal preparations, a scenario that is benefiting brands such as Panpyrin Q, Pancold S, Haben, Care Gargle, and other cold-related treatments by major pharmaceutical companies. Sales of these products in late 2021 and early 2022 increased rapidly due to a surge in number of confirmed Omicron cases in South Korea, encouraging consu...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
29 Pages
- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
- Euromonitor International
- October 2022
- List Of Contents And Tables
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SOUTH KOREA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Early 2022 surge in demand for cough, cold and allergy (hay fever) remedies due to Omicron variant
- Government drives increase in production of cough and cold medicines
- Increasing number of consumers buy cough and cold medicines from convenience stores and small local grocers for greater convenience
- PROSPECTS AND OPPORTUNITIES
- Sales set to rise heading into forecast period due to greater out-of-home mobility
- Worsening environmental conditions to drive growth in allergy-related products
- Pharmaceutical companies plan to diversify their business as COVID-19 increasingly perceived as endemic
- CATEGORY DATA
- Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
- Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
- Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
- Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
- Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN SOUTH KOREA
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2021-2022
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.